Literature DB >> 14668532

TOR signaling.

Thurl E Harris1, John C Lawrence.   

Abstract

The mammalian target of rapamycin, mTOR, is a protein Ser-Thr kinase that functions as a central element in a signaling pathway involved in the control of cell growth and proliferation. The activity of mTOR is controlled not only by amino acids, but also by hormones and growth factors that activate the protein kinase Akt. The signaling pathway downstream of Akt leading to mTOR involves the protein products of the genes mutated in tuberous sclerosis, TSC1 and TSC2, and the small guanosine triphosphatase, Rheb. In cells, mTOR is found in a complex with two other proteins, raptor and mLST8. In this review, we describe recent progress in understanding the control of the mTOR signaling pathway and the role of mTOR-interacting proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668532     DOI: 10.1126/stke.2122003re15

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  112 in total

Review 1.  TOR pathway: linking nutrient sensing to life span.

Authors:  Pankaj Kapahi; Brian Zid
Journal:  Sci Aging Knowledge Environ       Date:  2004-09-08

Review 2.  A renaissance of metabolite sensing and signaling: from modular domains to riboswitches.

Authors:  George W Templeton; Greg B G Moorhead
Journal:  Plant Cell       Date:  2004-09       Impact factor: 11.277

3.  Sideways glance: does dietary restriction promote longevity, though impairing fecundity? Not necessarily, if the diet has a correct nutrient balance.

Authors:  Sancia Gaetani; Fabio Virgili
Journal:  Genes Nutr       Date:  2010-03-05       Impact factor: 5.523

4.  Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.

Authors:  Delphine Boulbes; Chien-Hung Chen; Tattym Shaikenov; Nitin K Agarwal; Timothy R Peterson; Terri A Addona; Hasmik Keshishian; Steven A Carr; Mark A Magnuson; David M Sabatini; Dos D Sarbassov
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

5.  Regulation of G0 entry by the Pho80-Pho85 cyclin-CDK complex.

Authors:  Valeria Wanke; Ivo Pedruzzi; Elisabetta Cameroni; Frédérique Dubouloz; Claudio De Virgilio
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

6.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

Authors:  Qian Yang; Ken Inoki; Eunjung Kim; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

7.  mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70(S6k).

Authors:  Troy Alan Hornberger; Kunal Balu Sukhija; Xiao-Rong Wang; Shu Chien
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

8.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.

Authors:  Hernan Roca; Zachary S Varsos; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 10.  mTOR: taking cues from the immune microenvironment.

Authors:  Greg M Delgoffe; Jonathan D Powell
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.